Adamis Pharmaceuticals | ADMP - EPS Earnings Per Share


Adamis Pharmaceuticals reported $-0.06 in EPS Earnings Per Share for its fiscal quarter ending in March of 2023.



Eps Change Date
Adma Biologics USD 0.2 0.05 Dec/2025
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
CSL USD 5.07 3 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.21 0.51 Dec/2025
Grifols EUR 0.29 0.11 Mar/2026
Merck USD 2.04 0.54 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
RedHill Biopharma USD -1.31 33.38 Jun/2024